LONDON, June 15, 2023 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in the US. With this ...
Builds on company's growing position in Canadian sterile injectables market LONDON, March 9, 2023 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results